News + Events

Difficulty Breathing?

  • Fri, 01/03/2014
    Dr. Don Sin ranked with top COPD experts worldwide

    Dr. Don Sin, Canada Research Chair in Chronic Obstructive Pulmonary Disease (COPD) and Head, Division of Respiratory Medicine, Providence Health Care, was recently ranked as the second leading COPD expert in the world by Expertscape.com, a medical search and ranking website that ranks physicians, clinicians and researchers worldwide using a PubMed-based algorithm.

    Dr. Sin's research interests include finding new solutions to reduce the growing burden of COPD in Canada by discovering a simple blood test to diagnose acute lung attacks early in their course and new therapies to treat COPD-related co-morbidities such as cardiovascular disease.

    Q & A with Dr. Sin:

    What do you see as the leading challenges in COPD research?

    COPD is a heterogeneous disease with many different "faces." It is unlikely that we will find one solution that fits all. Our biggest challenge is unraveling these different faces of COPD and understanding their molecular mechanisms. Then, we will be able to design new biomarkers and new therapies to reduce the growing burden of COPD in Canada and elsewhere.

    In your opinion, what has been one of the most influential discoveries in COPD research?

    We have discovered that bronchodilators are effective and safe therapies to improve lung function, reduce symptoms and lower the risk of exacerbations in COPD patients. We have also discovered that COPD is a risk factor (i.e. gateway) for other common diseases such as heart disease, stroke, and lung cancer. Thus, the overall human impact of COPD is enormous.

    What are questions we must answer to help us better understand this disease?

    We need to find out how many different faces of COPD exist and are relevant for patient outcomes. This will enable breakthroughs in new biomarker and therapeutic discoveries that can make a difference to patient care. We also need to understand the molecular drivers of COPD (and its different phenotypes) and design appropriate therapeutic trials to treat or even reverse the phenotypes.

    What do you see as the future directions of COPD research?

    COPD research will continue to grow in size and scope. It is clear that small, one-lab research programs will not be adequate to address the important questions in COPD. Furthermore, the traditional "silos' of research in COPD will become increasingly obsolete. Researchers from all 4 CIHR pillars (basic biomedical, clinical, health services and population health) will work in large projects that will be truly translational and impactful on patient care. To this end, the recently formed Canadian Respiratory Research Network and the Genome Canada COPD Biomarker Projects are examples of what the future will look like in COPD research.

    For more information:
  • Wed, 12/11/2013
    New treatment for chronic obstructive pulmonary disease
    For more information:
  • Thu, 09/19/2013
    Free COPD Public Forum - Speaker and Health Fair

    Wednesday December 4th 1200-1600

    The Sheraton Vancouver Wall Centre

    Pavilion Ballroom

    1088 Burrard Street

    Vancouver BC V6Z 2R9

    www.sheratonvancouver.com

    Please RSVP for the forum to Kelly at The BC Lung Association:

    T 604.731.5864 x234

    E ablog@bc.lung.ca

  • Sun, 09/01/2013
    Dr. James Hogg, 2013 recipient of the Canada Gairdner Wightman Award and 2010 Canadian Medical Hall of Fame inductee.

    On May 10, 2013, Dr. James Hogg, recipient of the 2013 Canada Gairdner Wightman Award, the premier award for leadership in medical science in Canada, a special event was held in honour of his stellar career as a leader, researcher and educator. Dr. James Hogg, Emeritus Professor at the University of British Columbia and Principal Investigator at the Centre for Heart Lung Innovation located at St. Paul's Hospital, delivered a presentation on his research in chronic obstructive pulmonary disease. His work has contributed significantly to the advancement of research in lung disease. As well, in 2010, Dr. James Hogg, one of Canada's leading pulmonary pathologists and the co-founder of the iCAPTURE Centre, joined 76 other Hall of Fame laureates in the Canadian Medical Hall of Fame. The Canadian Medical Hall of Fame is the world's only national Hall of Fame dedicated to celebrating the accomplishments of medical heroes.

    For more information:
  • Sat, 08/31/2013
    Walk In Spirometry Clinic now available

    Drop in spirometry is available at St. Paul's Hospital to improve access to breathing tests. The clinic is run by the pulmonary function lab at St. Paul's Hospital (8D Providence Wing) and runs Tuesday, Wednesday and Thursday from 8:00am to 11:30am and 1;00pm to 3:30pm. A referral from your family physician is required. See the information provided under speciality clinics.

    For more information:
  • Thu, 10/01/2009
    #1 COPD Research Centre in Canada

    In 2009, Sciencewatch.com placed UBC/St. Paul's Hospital the #1 COPD research center in Canada and #3 in the world only behind the Imperial College of London and Harvard University in Boston.

  • Wed, 09/30/2009
    Chronic Obstructive Pulmonary Disease: Reactive Past, Preventive Future Conference 2009

    Providence Health care held a major international conference on COPD in Feb 2009 where 20 of the leading COPD experts and academics from around the world attended our center for a 2 day conference. The proceedings of the conference have been published in the Proceedings of the American Thoracic Society.

  • Tue, 09/01/2009
    Providence Health Care researchers awarded CIHR grant

    Providence Health Care/iCAPTURE was awarded a 2.1 million dollar Canadian Institutes of Health Research (CIHR) Team Grant in Clinical Imaging of COPD lungs in 2009. The Principal Investigators are Dr. Harvey Coxson and Dr. Nestor Muller. Our application was ranked #1.

  • Mon, 08/31/2009
    Canadian Cohort Obstructive Lung Disease (CanCOLD)

    Providence Health Care and the iCAPTURE Centre, along with the Montreal Chest Institute in Montreal, Quebec are the co-lead centers for the Canadian Cohort Obstructive Lung Disease which will study the natural history of COPD from a population perspective. Principal Investigators include Dr. Wan Tan, respirologist in the Pacific Lung Health Centre COPD clinic and Dr. Jean Bourbeau from Montreal. CanCOLD aims to be the first study to characterize COPD among a random sample of Canadians using spirometry as one of the main outcome measures.